U.S. Markets closed

Teva Pharmaceutical Industries Limited (TEVA)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
17.19+0.04 (+0.23%)
At close: 4:00PM EDT
People also watch
MYLGILDNVSAMGNBMY
  • B
    B.
    B.
    Teva has no further debt due in 2017. Over the next three years, 2018-2020, Teva must repay $14 billion in debt, approximately 40% of the total debt outstanding. 2018's debt repayment of $5.4 billion should not be a significant problem with recent asset sales and cash flow. 2019 and 2020 will be a challenge but one Teva will overcome. The long-term view for Teva is very good as global population growth of the 65+ age group explodes. Between 2015 and 2030, population in the 65+ group is projected to increase approximately 60% or 369 million people. This is a huge increase and will greatly benefit Teva and all pharma companies as one of the biggest needs of this group will be pharmaceuticals.
  • L
    LA
    LA
    Back to 20 soon, then going up to 35...
  • p
    potz
    potz
    Congratulations!
    We have an upgrade !
    BTIG research upgrades TEVA to Buy, announces $24 target.
  • L
    LA
    LA
    Every law firm in the US wants to sue. The investors are the last thing on their minds. Someone needs to sue them...
  • B
    Brad Jickwoczoski
    Brad Jickwoczoski
    Teva's shares are so diluted already that I cannot see how you could dilute them more. Therefore paying the debt due in the next two years is no problem, either issuing additional common stock, or issuing a new debt, probably with higher interest rate.
    If the new CEO is really good, Teva could come out of it in a few years.
  • f
    fresh
    fresh
    lots of nonsense, shorts are not there to keep the stock down, they are there to open and close positions, and the bitter longs that where sitting high are doing the crying...no doubt a good current entry/buying opportunity
  • J
    Jedi Miromat
    Jedi Miromat
    ALERT: the crooked law firm of Smugg, Ars & Holes wants to remind investors to abuse the system and force a settlement. We'll earn amazing fees and make a fortune, while you might get 1% back in 8 years... it's a great deal. Remember, we're Smugg, Ars Holes, you can be too!
  • Z
    Zeke
    Zeke
    I don't want TEVA to be bought out. I want to see triple digits in 5-10 years, not 30 now. Many of you "longs" are going to sell yourself cheap at 18, 19, 20, 21, etc., whenever you are able to "get out whole". It's why individuals make 2% per year average, when market averages 10.5 % return.
  • f
    fresh
    fresh
    still getting the stock down 50% in one hit is something SEC needs to look into, isn't so ZEKE...lol. Makes chickens laugh....
  • J
    John
    John
    I say wipe out the divy 100% and cut the work force by 15%. This is not rock science........
  • L
    LA
    LA
    It should be at least 33 it will get back there eventually. The manipulations will have to stop at some point...
  • L
    LA
    LA
    You will see 20 and 30 not 13
  • Z
    Zeke
    Zeke
    There was a study years ago, concluding the best time to buy a company was after a dividend cut. Makes sense. What better to cause a plummet in sentiment and capitulation than that? That in addition to dougie's reference to the clear mechanical need for dividend focused funds, institutions, and individuals to make the needed adjustments in their portfolios.
  • J
    Jedi Miromat
    Jedi Miromat
    TEVA board is doing all the right things... new CEO, sell off non-core business $2.5b cash deals, renegotiate debt covenants, ..... TEVA is going to break out from here..... I was doubting yesterday, thinking the Shorts are right, but that fear is misguided, it's an absolute growth play at this price
  • l
    larry
    larry
    Question

    Any financial people out there with a well reasoned guess as to when they could restore some more of the dividend based on current cash flow projections and debt payments
  • g
    guy
    guy
    a big one may be using the good news to get out of a short term position built below $17. whoever it is will sell all he has and we'll continue the way up. yesterday news about "debt concerns" push out from Dec'17 to Dec'18 give the company the pressure ease to operate and the stock justification to raise to the $20+ area.
  • J
    Jedi Miromat
    Jedi Miromat
    The 5 big issues in August were;
    1) no CEO
    2) divestiture of women's biz only theory
    3) concerns of non-compliance with bank
    4) copaxone 40mg
    5) overall increase generics competition

    but today we have;
    1) a CEO (experienced in turnaround)
    2) $2.5b sales of women's biz (3 transactions)
    3) renegotiated with banks, greater flexibility
    4) copaxone still an issue, but only starting Q4'18
    5) news that generics is stabilizing

    - Lowered guidance is an issue, creates caution

    - Chopping the dividend still an issue, but a financially helpful issue

    BUT the drop was so severe, this should recover based on the several good things

    The 6% drop Monday on the positive asset sale news makes nervous

    I don't know what to think.... flip a coin
  • J
    John
    John
    im happy my order was filled last night. i think a lot of people on this site know the game and also know this is a great place to buy the stock. good luck to everyone im done commenting. will check back in when i close out my double or triple in 3 to 6 months
  • F
    Fargos
    Fargos

    Teva Stock Could Double
    http://www.barrons.com/articles/teva-pharmaceutical-stock-could-double-1505993839

    Teva Pharmaceutical Stock Could Double
    The Israeli firm has had troubled times, but with a new CEO in place shares could recover through 2020.
    www.barrons.com
  • J
    John
    John
    if all is doom and gloom why cant i get filled for 17.10? wish i would have doubled my position yesterday it would have been great to catch the bottom.